Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Clomipramine (fluoxetine plus clomipramine)
Total 0 results
Nothing found
Sponsors and Collaborators
Accunea Ltd.
Aryn Knight
Lishui Hospital of TCM
Radiomedix, Inc.
Francine Behar-Cohen
Mitaka USA, Inc.
Third Affiliated Hospital of Third Military Medical University
Refocus Group, Inc.
LuEsther T. Mertz Retinal Research Center
Congressionally Directed Medical Research Programs
Zhiwu Huang, Ph.D.
Association for the Blind and Visually Impaired
Central Institute of Psychiatry, Ranchi, India
National Institute of Health and Medical Research 1061, Montpellier
Richard M. Fairbanks School of Public Health AT IUPUI
Private Ortopedia Hospital, Seyhan Adana
Erol Aktunc
APT Foundation, Inc.
Cure Cancer Worldwide Corporation
Key Tech
View Full List
Medical Conditions
Malignant Tumor of Urinary System (Disorder)
Parental
Neuroectodermal Tumor
Urinary Bladder Neurogenic Dysfunction
Root Abscess
Anticoagulant Prophylaxis/Therapy
Control Nausea and Vomiting
Humerus Fracture Displaced Proximal
Bladder Cancer Recurrent
Pharmacokinetics of Ipragliflozin
Bladder Recurrence
Macrocephaly Autism Syndrome
Endoscopic Surveillance
Memory Disorders
Poor Medication Adherence
0.5-14 Year Old Children With Nephroblastoma
Atherosclerosis Coronary Artery With Angina Pectoris
Small Intestine Cancer
Granulomatous Disease, Chronic
Inoperable Stage III Non-small Cell Lung Cancer
View Full List
Drug Interventions
Sparsentan
Salvinorin A
APG2575 800 mg
Elafibranor 80mg
Bupropion Extended Release Oral Tablet
SAR408701 (Tusamitamab ravtansine)
Campath 1H
Letrozole
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
The drug "Rutan 0.1".
Varenicline Controlled Release 1.2 mg
Ceralasertib
Biphasic insulin aspart 30
Idelalisib
Clozapine 100 mg
Vehicle
Cyclosporine A
FTD regimen
Fibrin Sealant
Everolimus
View Full List
CROs by country
Contract Research Organizations in El Salvador
Contract Research Organizations in Finland
Contract Research Organizations in Guatemala
Contract Research Organizations in Kenya
Contract Research Organizations in Latvia
Contract Research Organizations in Lebanon
Contract Research Organizations in Macedonia
Contract Research Organizations in Qatar
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Serbia
Contract Research Organizations in Sweden
Contract Research Organizations in Tunisia
Contract Research Organizations in Ukraine
CRO list by country
CROs in Malawi
SGS
All CROs in Malawi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe